Analysts Hail Pearson's Return To Valeant As Patent Challenges From Allergan LoomsMark Melin
Patent challenges, restatement of earnings and lack of forward looking guidance are all greeting Michael Pearson, Valeant's former Chairman and CEO, who is coming back to the firm today. Pearson's job responsibilities are being clipped, with his chairman title being an oversight role at Valeant to be executed by Robert A. Ingram, a former executive of GlasxoSmithKline, the company announced over the weekend.
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.